ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,101.24
-0.29%
Dow Jones
44,424.25
-0.32%
US Dollar vs MXN
20.2749
0.00%
Brent Oil
77.625
0.00%
Bitcoin
104,652.45
-0.07%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Argent Biopharma Limited (RGT)

  7. Argent Biopharma Limited (RGT) Noticias

RGT

Argent Biopharma (RGT)

Argent Biopharma Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:RGT
FechaHoraFuenteTítuloSímboloCompañía
31/12/202402:00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Argent Biopharma LimitedLSE:RGTArgent Biopharma Limited
16/12/202402:13RNS Non-RegulatoryArgent Biopharma Limited Additional Information for ShareholdersLSE:RGTArgent Biopharma Limited
29/11/202405:52Alliance NewsAlliance NewsArgent BioPharma to delist from LSE; hints at future dual US listingLSE:RGTArgent Biopharma Limited
29/11/202401:00RNS Regulatory NewsArgent Biopharma Limited ASX & LSE Listing UpdateLSE:RGTArgent Biopharma Limited
28/11/202403:09RNS Regulatory NewsArgent Biopharma Limited Result of AGMLSE:RGTArgent Biopharma Limited
31/10/202402:00RNS Regulatory NewsArgent Biopharma Limited September 2024 Quarterly ReportLSE:RGTArgent Biopharma Limited
25/10/202401:13RNS Regulatory NewsArgent Biopharma Limited Dispatch of Annual General Meeting DocumentsLSE:RGTArgent Biopharma Limited
24/10/202401:24RNS Regulatory NewsArgent Biopharma Limited Placing to Raise A$200,000LSE:RGTArgent Biopharma Limited
15/10/202402:56RNS Regulatory NewsArgent Biopharma Limited Holding(s) in CompanyLSE:RGTArgent Biopharma Limited
15/10/202402:54RNS Regulatory NewsArgent Biopharma Limited Director/PDMR ShareholdingLSE:RGTArgent Biopharma Limited
10/10/202403:10Alliance NewsAlliance NewsIN BRIEF: Argent BioPharma refinances AUD300,000 in convertible notesLSE:RGTArgent Biopharma Limited
09/10/202401:00RNS Regulatory NewsArgent Biopharma Limited Refinancing of Convertible Security AgreementLSE:RGTArgent Biopharma Limited
01/10/202404:33RNS Regulatory NewsArgent Biopharma Limited Result of MeetingLSE:RGTArgent Biopharma Limited
30/09/202403:34RNS Regulatory NewsArgent Biopharma Limited Annual Report for the year ended 30 June 2024LSE:RGTArgent Biopharma Limited
25/09/202401:50RNS Regulatory NewsArgent Biopharma Limited Date of AGM & Closing Date of Director NominationsLSE:RGTArgent Biopharma Limited
23/09/202401:24RNS Regulatory NewsArgent Biopharma Limited ASX Delisting UpdateLSE:RGTArgent Biopharma Limited
10/09/202401:00RNS Non-RegulatoryArgent Biopharma Limited CannEpil - Technical OverviewLSE:RGTArgent Biopharma Limited
09/09/202401:00RNS Non-RegulatoryArgent Biopharma Limited CimetrA - Technical OverviewLSE:RGTArgent Biopharma Limited
06/09/202401:00RNS Regulatory NewsArgent Biopharma Limited Company PresentationLSE:RGTArgent Biopharma Limited
30/08/202412:37Alliance NewsAlliance NewsIN BRIEF: Argent Biopharma loss narrows amid investment gainLSE:RGTArgent Biopharma Limited
30/08/202401:10RNS Regulatory NewsArgent Biopharma Limited 30 June 2024 Preliminary Financial ReportLSE:RGTArgent Biopharma Limited
27/08/202401:05RNS Regulatory NewsArgent Biopharma Limited Letter from the CEOLSE:RGTArgent Biopharma Limited
27/08/202401:00RNS Regulatory NewsArgent Biopharma Limited Notice of General MeetingLSE:RGTArgent Biopharma Limited
21/08/202415:55Alliance NewsAlliance NewsTRADING UPDATES: Hellenic Dynamics loan delay; Argent's Sintef tie-upLSE:RGTArgent Biopharma Limited
21/08/202401:00RNS Regulatory NewsArgent Biopharma Limited SINTEF Collaboration for Chronic Wound ManagementLSE:RGTArgent Biopharma Limited
15/08/202401:20RNS Regulatory NewsArgent Biopharma Limited Voluntary Delisting From ASXLSE:RGTArgent Biopharma Limited
30/07/202402:00RNS Regulatory NewsArgent Biopharma Limited June 2024 Quarter Activity Report and Cash FlowLSE:RGTArgent Biopharma Limited
16/07/202414:23Alliance NewsAlliance NewsTRADING UPDATES: Cirata to raise cash; Cap-XX teams with SchurterLSE:RGTArgent Biopharma Limited
16/07/202403:58RNS Regulatory NewsArgent Biopharma Limited Placing to Raise US$2,000,000LSE:RGTArgent Biopharma Limited
01/07/202401:00RNS Regulatory NewsArgent Biopharma Limited Placing to Raise US$500,000LSE:RGTArgent Biopharma Limited
 Showing the most relevant articles for your search:LSE:RGT

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
COIN
XRPUSD
Ripple
USI
USTECH100
US Tech 100
USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
CCOM
US30
US 30
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
NYSE
AXP
American Express
COIN
AVAXUSD
Avalanche
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados